Related Experiment Video
Updated: Jun 26, 2026

Measuring Lactase Enzymatic Activity in the Teaching Lab
Published on: August 6, 2018
Lactase Deficiency in 2026: Understanding Pathophysiology, Global Persistence Trends, and Targeted Therapies for
Mayank Goyal1, Navjot Kaur Sandhu1
1Department of Quality Assurance, ISF College of Pharmacy, Moga, Punjab, India.
Lactose intolerance affects 68% of the global population due to insufficient lactase enzyme. This condition impacts nutrient intake, despite a growing therapeutic market for management solutions.
Area of Science:
- Gastroenterology
- Human Physiology
- Nutritional Science
Background:
- Lactose intolerance is a widespread digestive disorder caused by inadequate lactase enzyme production, hindering lactose breakdown.
- Lactose, a sugar in mammal milk, is vital for infant energy but its digestion varies globally, with lactase persistence rates differing significantly by region.
- Approximately one-third of adults can digest dairy, yet many avoid it due to perceived negative effects, risking nutrient deficiencies.
Purpose of the Study:
- To summarize the global prevalence and regional variations of lactose intolerance.
- To highlight the nutritional implications of dairy avoidance in lactose-intolerant individuals.
- To provide an overview of the expanding therapeutic market for lactose intolerance management.
Main Methods:
- Literature review on global lactose intolerance prevalence and regional lactase persistence data.
- Analysis of nutritional impacts associated with dairy product restriction.
- Market analysis of the therapeutic sector for lactose intolerance.
Main Results:
- About 68% of the world's population experiences lactose intolerance, with significant regional disparities (e.g., 5-28% in Europe vs. 70-98% in Asia and Africa).
- Dairy avoidance can lead to deficiencies in essential nutrients like protein, vitamins, and minerals.
- The global therapeutic market for lactose intolerance is projected to grow from $36.96 billion in 2026 to $49.13 billion by 2030.
Conclusions:
- Lactose intolerance is a common condition with substantial global and regional variations.
- Managing lactose intolerance requires attention to nutritional adequacy and awareness of available therapeutic interventions.
- The market for lactose intolerance treatments, including supplements and dairy alternatives, is experiencing robust growth.
Related Concept Videos
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Lysosomal Hydrolases
Clinical Significance of Antibiotic Resistance
Pharmacogenomics: Identification of New Drug Targets
Inborn Errors of Metabolism
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
